The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMarlowe Regulatory News (MRL)

Share Price Information for Marlowe (MRL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 571.00
Bid: 566.00
Ask: 576.00
Change: -10.00 (-1.72%)
Spread: 10.00 (1.767%)
Open: 575.00
High: 578.00
Low: 570.00
Prev. Close: 580.00
MRL Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Issue of Equity and Total Voting Rights

26 Jan 2022 07:00

RNS Number : 6084Z
Marlowe PLC
26 January 2022
 

26 January 2022

 

 

Marlowe plc

("Marlowe", the "Company" or the "Group")

 

 

Issue of Equity and Total Voting Rights

 

 

Marlowe, the UK leader in business-critical services and software which assure regulatory compliance, announces that, following the achievement of profit targets in respect of the Group's 2020 acquisition of Elogbooks Facilities Management Limited and Elogbooks Facilities Services Limited (together with their subsidiaries, "Elogbooks"), final contingent consideration of £3.5m, including the issue of 93,016 new ordinary shares of 50 pence each in the Group (the "New Ordinary Shares") at an effective issue price of 1025 pence per ordinary share, will be payable by the Group in respect of the Acquisition.

 

Application has been made for 93,016 New Ordinary Shares to be admitted to trading on AIM ("Admission"). The New Ordinary Shares will rank pari passu with the Group's existing ordinary shares, and it is expected that Admission will occur at 8.00am on 27 January 2022.

 

Following Admission, the Company's issued ordinary share capital will comprise 95,833,853 ordinary shares, none of which are held in treasury. Therefore, the total number of ordinary shares with voting rights in Marlowe following admission will be 95,833,853 ordinary shares.

 

The above figure of 95,833,853 may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in the Company under the FCA's Disclosure Guidance and Transparency Rules.

 

 

For further information:

 

Marlowe plc

 

www.marloweplc.com

Alex Dacre, Chief Executive

Tel: +44 (0) 203 841 6194

Adam Councell, Chief Financial Officer

IR@marloweplc.com

Julian Wais, Head of Investor Relations

Cenkos Securities plc

Nominated Adviser and Joint Broker

Tel: +44 (0)20 7397 8900

Nicholas Wells

Ben Jeynes

George Lawson

Joh. Berenberg, Gossler & Co. KG, London Branch

Joint Broker

Tel: +44 (0)20 3207 7800

Mark Whitmore

Ben Wright

Dan Gee-Summons

 

FTI Consulting

Tel: +44 (0)20 3727 1340

Nick Hasell

Alex Le May

 

 

About Marlowe plc

 

Marlowe is a UK leader in business-critical services and software which assure safety and regulatory compliance. The company was formed to create sustainable shareholder value through the acquisition and development of businesses that provide regulated safety and compliance services. It is focused on compliance software, eLearning, health & safety, employment law & HR compliance, fire safety & security, water & air hygiene and occupational health services - all of which are vital to the wellbeing of its customers operations and are invariably governed by regulation. Marlowe currently provides software to over 1 million users and services to over 25% of Britain's commercial premises. The Group provides customers with a single outsourced, nationwide, provider of a range of regulated compliance and safety solutions. Our customers can be found in office complexes, high streets & leisure facilities, manufacturing plants and industrial estates, and include thousands of SMEs, local authorities, facilities management providers, multi-site NHS trusts and FTSE 100 companies.

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TVRBAMFTMTJTBBT
Date   Source Headline
17th Nov 20227:00 amRNSNotice of Interim Results
2nd Nov 20225:08 pmRNSHolding(s) in Company
19th Oct 202210:40 amRNSExercise of Share Options and Total Voting Rights
14th Oct 20223:12 pmRNSHolding(s) in Company
11th Oct 20221:40 pmRNSHolding(s) in Company
10th Oct 20222:06 pmRNSHolding(s) in Company
21st Sep 20224:18 pmRNSHolding(s) in Company
20th Sep 20222:02 pmRNSHolding(s) in Company
14th Sep 202211:56 amRNSResult of Annual General Meeting
14th Sep 20227:00 amRNSAGM Statement
2nd Sep 20229:41 amRNSHolding(s) in Company
30th Aug 20227:00 amRNSLaunch of Group 2022 SAYE Scheme
16th Aug 20223:38 pmRNSExercise of Share Options and Total Voting Rights
9th Aug 20227:00 amRNSPublication of Notice of AGM and Annual Report
8th Aug 20227:00 amRNSChange of Auditor
7th Jul 20225:14 pmRNSDirector/PDMR Shareholding
5th Jul 20222:24 pmRNSExercise of Share Options and Total Voting Rights
4th Jul 20223:54 pmRNSExercise of Share Options and Total Voting Rights
4th Jul 20222:10 pmRNSDirector/PDMR Shareholding
1st Jul 20227:00 amRNSPublication of Annual Report
28th Jun 20227:00 amRNSFinal Results
23rd Jun 20227:00 amRNSNotice of Full Year Results Analyst Presentation
8th Jun 20227:00 amRNSAcquisition of HR Solutions
25th May 20227:00 amRNSAcquisition of Cedrec Information Systems Limited
23rd May 202212:55 pmRNSExercise of Share Options and Total Voting Rights
28th Apr 20224:22 pmRNSHolding(s) in Company
28th Apr 20224:18 pmRNSHolding(s) in Company
26th Apr 20224:36 pmRNSExercise of Share Options and Total Voting Rights
19th Apr 20227:00 amRNSAcquisition of TP Health
11th Apr 202210:47 amRNSExercise of Share Options
5th Apr 20223:05 pmRNSCapital Markets Day Replay
5th Apr 20227:00 amRNSCapital Markets Day
22nd Mar 20227:00 amRNSAcquisition of Griffin Fire
21st Mar 20227:00 amRNSNotice of Capital Markets Day and Trading Update
15th Mar 20227:00 amRNSAppointment of Joint Corporate Broker
17th Feb 20227:00 amRNSDirectorate Change
11th Feb 20227:00 amRNSAcquisition of S F Fire Limited
10th Feb 20227:00 amRNSNew Enlarged Debt Facility
31st Jan 202212:20 pmRNSHolding(s) in Company
28th Jan 20222:19 pmRNSDirector/PDMR Shareholding
27th Jan 20229:07 amRNSHolding(s) in Company
26th Jan 202211:39 amRNSDirector/PDMR Shareholding
26th Jan 20227:00 amRNSIssue of Equity and Total Voting Rights
21st Jan 20221:08 pmRNSHolding(s) in Company
20th Jan 20224:08 pmRNSResults of Placing
20th Jan 20227:48 amRNSProposed Placing and Acquisition of Optima Health
20th Jan 20227:00 amRNSAcquisition of Optima Health
19th Jan 202212:13 pmRNSAppointment of Independent Non-Executive Director
14th Jan 20225:01 pmRNSExercise of Share Options
20th Dec 20217:00 amRNSAcquisition of Skill Boosters

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.